Animal Models of T Cell-Mediated Skin Diseases

Pharmaceutical companies are spending increasing amounts of money on drug discovery and development. Nevertheless, attrition rates in clinical development are still very high, and up to 90% of new compounds fail in clinical phase I - III trials, which is partially due to lack of clinical efficacy. T...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Zollner, T. (Editor,, Renz, Harald. (Editor,, Asadullah, Khusru. (Editor,
Format: Electronic eBook
Published: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2005.
Edition:1st ed. 2005.
Series:Ernst Schering Foundation Symposium Proceedings, 50
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!